drugset / Trial / NCT03204578

Physiological Study of the Human CYP3A Activity (PiSA)

NCT03204578

Phase 4 Completed 12 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverOpen-labelTreatment

Summary

Investigator-initiated physiological study to characterize the function of a major drug metabolizing enzyme using a microdosed phenotyping probe to avoid unwanted, concentration-dependent effects.

Timeline

Start
2017-08-18
Primary completion
2017-09-25
Completion
2017-09-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 30 ug Oral

Indications

No indication recorded.